Phase II Clinical Study to Evaluate the Efficacy of Multidose Lagricel® Ofteno Ophthalmic Solution as Treatment for Dry Eye Disease.
Conditions
Interventions
- DRUG: Sodium Hyaluronate Ophthalmic 0.4% one drop twice a day (BID)
- DRUG: Sodium Hyaluronate Ophthalmic 0.4% one drop four times a day (QID)
- DRUG: Sodium Hyaluronate Ophthalmic 0.4% Six times per day
Sponsor
Laboratorios Sophia S.A de C.V.